ARTICLE | Clinical News
Azor/Sevikar olmesartan/amlodipine regulatory update
July 15, 2013 7:00 AM UTC
FDA issued a drug safety communication warning that hypertension drug olmesartan can cause intestinal problems known as sprue-like enteropathy, which includes symptoms such as severe, chronic diarrhea...